Marshall & Sullivan Inc Danaher Corp Transaction History

Marshall & Sullivan Inc

  • $192 Million
  • Q2 2024

A detailed history of Marshall & Sullivan Inc transactions in Danaher Corp stock. As of the latest transaction made, Marshall & Sullivan Inc holds 23,195 shares of DHR stock, worth $6.26 Million. This represents 3.02% of its overall portfolio holdings.

Number of Shares
23,195
Previous 23,687 2.08%
Holding current value
$6.26 Million
Previous $5.92 Million 2.03%
% of portfolio
3.02%
Previous 3.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024
SELL
$235.51 - $267.98 $115,870 - $131,846
-492 Reduced 2.08%
23,195 $5.8 Million
Q1 2024

Apr 10, 2024
SELL
$224.58 - $256.19 $449 - $512
-2 Reduced 0.01%
23,687 $5.92 Million
Q4 2023

Jan 11, 2024
SELL
$185.1 - $233.13 $13,697 - $17,251
-74 Reduced 0.31%
23,689 $5.48 Million
Q3 2023

Oct 06, 2023
SELL
$233.08 - $265.59 $86,705 - $98,799
-372 Reduced 1.54%
23,763 $5.9 Million
Q2 2023

Jul 12, 2023
BUY
$224.99 - $256.14 $53,097 - $60,449
236 Added 0.99%
24,135 $5.79 Million
Q1 2023

Apr 10, 2023
BUY
$239.75 - $277.0 $34,524 - $39,888
144 Added 0.61%
23,899 $6.02 Million
Q4 2022

Jan 18, 2023
SELL
$241.42 - $282.29 $242,627 - $283,701
-1,005 Reduced 4.06%
23,755 $0
Q3 2022

Oct 28, 2022
SELL
$247.06 - $1507.4 $18,035 - $110,040
-73 Reduced 0.29%
24,760 $6.4 Million
Q2 2022

Jul 06, 2022
BUY
$237.11 - $299.66 $9,721 - $12,286
41 Added 0.17%
24,833 $6.3 Million
Q1 2022

May 02, 2022
SELL
$257.27 - $315.76 $338,567 - $415,540
-1,316 Reduced 5.04%
24,792 $7.27 Million
Q4 2021

Jan 24, 2022
SELL
$292.08 - $329.01 $70,975 - $79,949
-243 Reduced 0.92%
26,108 $8.59 Million
Q3 2021

Oct 19, 2021
SELL
$272.21 - $332.43 $554,491 - $677,159
-2,037 Reduced 7.18%
26,351 $8.02 Million
Q2 2021

Aug 09, 2021
BUY
$225.08 - $271.69 $30,385 - $36,678
135 Added 0.48%
28,388 $7.62 Million
Q1 2021

May 04, 2021
BUY
$212.38 - $245.9 $4.67 Million - $5.41 Million
22,008 Added 352.41%
28,253 $6.36 Million
Q4 2020

Jan 29, 2021
SELL
$212.5 - $245.46 $4.72 Million - $5.45 Million
-22,198 Reduced 78.04%
6,245 $28.1 Million
Q3 2020

Nov 02, 2020
SELL
$177.16 - $215.33 $497,288 - $604,431
-2,807 Reduced 8.98%
28,443 $6.13 Million
Q2 2020

Jul 14, 2020
SELL
$128.7 - $176.83 $112,612 - $154,726
-875 Reduced 2.72%
31,250 $5.53 Million
Q1 2020

May 06, 2020
SELL
$121.39 - $169.05 $457,761 - $637,487
-3,771 Reduced 10.51%
32,125 $4.45 Million
Q4 2019

Jan 14, 2020
SELL
$133.47 - $153.48 $84,353 - $96,999
-632 Reduced 1.73%
35,896 $5.51 Million
Q3 2019

Oct 11, 2019
SELL
$135.4 - $146.47 $3,249 - $3,515
-24 Reduced 0.07%
36,528 $5.28 Million
Q2 2019

Aug 05, 2019
SELL
$124.88 - $143.73 $160,970 - $185,267
-1,289 Reduced 3.41%
36,552 $5.22 Million
Q1 2019

May 08, 2019
BUY
$97.62 - $132.29 $74,191 - $100,540
760 Added 2.05%
37,841 $5 Million
Q4 2018

Jan 28, 2019
SELL
$94.85 - $109.54 $50,365 - $58,165
-531 Reduced 1.41%
37,081 $3.82 Million
Q3 2018

Oct 29, 2018
BUY
$98.13 - $108.9 $37,093 - $41,164
378 Added 1.02%
37,612 $4.09 Million
Q2 2018

Jul 31, 2018
BUY
$96.1 - $103.24 $76,783 - $82,488
799 Added 2.19%
37,234 $0
Q1 2018

Apr 30, 2018
SELL
$92.16 - $103.8 $46,080 - $51,900
-500 Reduced 1.35%
36,435 $3.57 Million
Q4 2017

Feb 09, 2018
SELL
$85.26 - $94.62 $34,189 - $37,942
-401 Reduced 1.07%
36,935 $3.43 Million
Q3 2017

Nov 09, 2017
BUY
$79.29 - $88.45 $56,375 - $62,887
711 Added 1.94%
37,336 $3.45 Million
Q2 2017

Aug 09, 2017
BUY
N/A
36,625
36,625 $3.09 Million

Others Institutions Holding DHR

# of Institutions
2,384
Shares Held
558M
Call Options Held
3.53M
Put Options Held
3.97M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $197B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Marshall & Sullivan Inc Portfolio

Follow Marshall & Sullivan Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall & Sullivan Inc , based on Form 13F filings with the SEC.

News

Stay updated on Marshall & Sullivan Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email